Q1 2019
Released May 8, 2019, after the close
10-Q filed May 8, 2019, 38 days after period end · 0001493152-19-006579
Q1 2019 · 10-Q
Revenue$1.77M$1.77M +79.6% vs Q1 2018+9.7% vs Q4 2018
Net Income-$1.35M-$1.35M N/M vs Q1 2018N/M vs Q4 2018
EPS Diluted-$0.20-$0.20 N/M vs Q1 2018no prior Q4 2018 on file
Gross Profit$998,000+113.7%
Operating Income-$1,301,000N/M
Operating Cash Flow-$697,000N/M
Margins · derived
Gross margin56.4%+9.0 pt vs Q1 2018
Operating margin-73.5%+40.5 pt vs Q1 2018
Net margin-76.3%+68.8 pt vs Q1 2018
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $1.77M | $985.00K | $734.00K | $590.00K |
| Net Income | -$1.35M | -$1.43M | -$680.00K | -$836.00K |
| EPS Diluted | -$0.20 | -$0.03 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR